KRYS

Krystal Biotech, Inc.

KRYS·501147102·US·Common Stock·Healthcare - Biotechnology-13D/G

KRYS (Krystal Biotech, Inc.) is held by 176 institutional investors as of Q2 2026. Largest holders: FMR LLC ($1.6B), BlackRock, Inc. ($1.6B), Avoro Capital Advisors LLC ($1.1B). Net institutional sentiment: Mixed.

176
Holders
(13 Elite)
$9.3B
Total Value
62% (185)
Consensus
114 buying - 71 selling
13F: Insider & Congress: Updated regularly
KRYS

Smart Money Verdict

View all
Loading verdict
Held by 176 funds
13 elite

Who's Trading

Source dates: Price Aug 21, 2026 · Insiders Jun 26, 2026 · Activists May 4, 2026 · Congress none

InsiderTCThomas John CharlesSell $347KJun 25, 2026
ActivistKSKrish S. Krishnan11.5%May 4, 2026
ActivistVPVanguard Portfolio Management5.0%Apr 29, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
4.4M(+1.0%)$1.6B0.1%+113.08%
32
Increased
4.2M(+6.1%)$1.6B0.0%+98.89%
34
Unchanged
2.9M$1.1B9.6%+230.25%
0
Increased
1.6M(+8.1%)$585.3M0.0%+27.47%
34
Increased
1.4M(+2.8%)$502.2M0.0%+129.57%
32
Increased
1.2M(+6.5%)$461.1M0.0%+28.20%
33
Decreased
777,843(-5.7%)$289.1M0.0%+87.76%
0
Increased
698,993(+8.5%)$259.8M0.0%+195.72%
33
Increased
663,375(+7.1%)$246.6M1.8%+212.69%
52
Increased
570,153(+40.0%)$211.9M0.6%+33.58%
57
Increased
476,038(+1.5%)$176.9M0.0%+240.56%
31
Decreased
324,900(-7.3%)$120.8M0.1%+89.47%
0
Increased
324,755(+29.2%)$120.7M0.0%+28.17%
38
Increased
298,841(+39.0%)$111.1M0.0%+64.37%
40
Increased
283,784(+12.4%)$105.5M0.0%+215.12%
34
Increased
261,917(+46.1%)$97.3M0.0%+21.85%
41
Decreased
256,431(-1.6%)$95.3M0.0%+68.43%
0
Increased
254,828(+5.3%)$94.7M0.0%+228.09%
32
Increased
235,491(+12.6%)$87.5M0.0%+69.26%
34
Increased
189,528(+5.8%)$70.4M0.0%+28.51%
31

Showing 1-20 of 193

1 / 10
KRYSKRYSKrystal Biotech, Inc.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used